Camille Planty

发表

Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity.

P. Chomez, H. Carlsen, Abdelatif Elouahabi, 2011, Vaccine.

Signal management in pharmacovigilance and human risk assessment of CpG 7909, integrating embryo-fetal and post-natal developmental toxicity studies in rats and rabbits.

N. Garçon, J. Stegmann, Frédérique Delannois, 2018, Reproductive toxicology.

Repeated-Dose Toxicity, Biodistribution, and Shedding Assessments With a ChAd155 Respiratory Syncytial Virus Vaccine Candidate Evaluated in Rabbits and Rats

A. Rogue, Giulietta Maruggi, P. Ancian, 2022, International journal of toxicology.

Efficacy of an AS03A-adjuvanted split H5N1 influenza vaccine against an antigenically distinct low pathogenic H5N1 virus in pigs.

S. Mossman, B. Baras, S. Giannini, 2012, Vaccine.

Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton rats

M. Boukhvalova, T. March, R. G. van der Most, 2017, Human vaccines & immunotherapeutics.

Nonclinical safety assessment of repeated administration and biodistribution of ChAd3‐EBO‐Z Ebola candidate vaccine

Clémentine Chalmey, M. Duclos, A. Steff, 2020, Journal of applied toxicology : JAT.